Key result
Pulse wave velocity links to ~14% higher progressive CKD risk per 1 m/s increase in T2D.
Why the study?
Associations between arterial stiffness-related hemodynamic parameters and renal outcomes remain controversial in individuals with type 2 diabetes.
Is pulse wave velocity associated with progressive chronic kidney disease in individuals with type 2 diabetes?
Cohort (n=1,444)
Yes
Is pulse wave velocity associated with progressive chronic kidney disease in individuals with type 2 diabetes?
Effect estimate: OR 1.14 (95% CI 1.01-1.29)
p-value: p=0.04
Carotid-femoral pulse wave velocity is an independent predictor of CKD progression in patients with type 2 diabetes and improves risk stratification beyond traditional risk factors.
PWV may refine CKD risk stratification in T2D beyond traditional factors; leaves open whether modifying it alters progression.
BACKGROUND: Pulse wave velocity (PWV), central pulse pressure and augmentation index are arterial stiffness- related hemodynamic parameters but their associations with renal outcome are still controversial. We hereby aim to study, 1) which hemodynamic parameter is independently associated with progressive chronic kidney disease (CKD), 2) the association of 3-year change in PWV with CKD progression and, 3) the additive predictive value of PWV for progressive CKD. METHODS: Carotid- femoral PWV, central pulse pressure and augmentation index were measured in 1444 participants with type 2 diabetes at baseline and 3 years apart. Progressive CKD was defined as confirmed eGFR decline 40% or greater. RESULTS: In the follow-up, 102 participants experienced progressive CKD. All 3 hemodynamic parameters were significantly associated with progressive CKD In univariable analysis. However, only PWV remained statistically significant after adjustment for known clinical risk factors and the other 2 hemodynamic parameters (OR 1.14 [95% CI 1.01-1.29] per m/s increment). One m/s regression (decrement) in PWV in the 3-year follow-up was associated with 26% lower adjusted- risk of progressive CKD (OR 0.74, 95% CI 0.56-0.97). Adding PWV onto traditional risk factor- based model significantly improved classification (net reclassification improvement 0.25, 95% CI 0.05-0.45, P = 0.01) and positive prediction rate (24.5 to 32.3%). CONCLUSIONS: Of 3 arterial stiffness- related hemodynamic parameters, only PWV is independently associated with progressive CKD. PWV may be a potential intervention target to mitigate risk of CKD progression and also a biomarker to improve risk-stratification of adverse renal outcome in individuals with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a cohort in Type 2 diabetes (n=1,444). Pulse wave velocity (PWV) was evaluated on Progressive CKD (confirmed eGFR decline ≥40%) (OR 1.14, 95% CI 1.01-1.29, p=0.04). Pulse wave velocity was the only arterial stiffness parameter independently associated with progressive chronic kidney disease in patients with type 2 diabetes (OR 1.14 per 1 m/s increment).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: